[Experimental basis fur using D-penicillamine in liver cirrhosis].

The therapeutic action of D-penicillamine (D-PA) in experimental liver cirrhosis was examined comprehensively and compared to that of prednisolone. D-RA primarily depressed fibrillogenesis, preventing the appearance of scar lesions in liver tissue. The drug exerted a beneficial effect on excretory and albumin-synthetizing function of the liver and had a protective action of oxidation function of liver mitochondria and the content of cytochromes.